Assignee
AXXAM SPA
IT·7 granted patents·1 pending application·6 citations·filing 2004–2019
Top patents by PatentIndex Score
8 records- 0165US7858394B2Test methods for determining the intracellular concentration of cyclic nucleotidesAXXAM SPA·Filed 2004·Granted Dec 28, 2010·5 cites·20 claims
- 0263US9718812B2Substituted thiazole or oxazole P2X7 receptor antagonistsAXXAM SPA·Filed 2015·Granted Aug 1, 2017·1 cites·8 claims
- 0348US7833749B2Isolated photoprotein mtClytin, and use thereofAXXAM SPA·Filed 2004·Granted Nov 16, 2010·0 cites·12 claims
- 0443US10167281B2Substituted thiazole or oxazole P2X7 receptor antagonistsAXXAM SPA·Filed 2017·Granted Jan 1, 2019·0 cites·5 claims
- 0540US10669267B2Substituted N-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and N-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives P2X7 receptor antagonistsAXXAM SPA·Filed 2017·Granted Jun 2, 2020·0 cites·7 claims
- 0639US11597702B2Substituted pyrazoles FFA4/GPR120 receptor agonistsAXXAM SPA·Filed 2019·Granted Mar 7, 2023·0 cites·9 claims
- 0736US11623919B2Heterocyclic P2X7 antagonistsAXXAM SPA·Filed 2018·Granted Apr 11, 2023·0 cites·8 claims
- 0834US2009286695A1Luminescent stem cells and uses thereofAXXAM SPA·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →